Grantback. Licensee agrees that any changes, improvements, or modifications in the method, apparatus, equipment, and/or process which Licensee makes or has made shall belong exclusively to Xxxxxxx, and that Xxxxxxx has full rights to patent, incorporate and utilize such changes or improvements into the Xxxxxxx Horizontal Technology.
Grantback. In consideration of the technology and rights licensed to ONCOMED herein, ONCOMED grants to MORPHOSYS a fully paid-up, non-exclusive, irrevocable, perpetual, worldwide, royalty-free license (with the right to sublicense), under Grantback Patent Rights, for the sole purpose of allowing MORPHOSYS and/or MORPHOSYS Third Party Licensees to utilize, develop and commercialize antibodies developed through the use of MORPHOSYS’ technology (including MORPHOSYS Technology), [***] (“Grantback License”).
Grantback. Notwithstanding anything in this Agreement to the contrary, Nuvelo hereby grants to Archemix a non-exclusive, paid-up, royalty-free license to any Nuvelo Technology and Nuvelo Patent Rights that generically relates to and covers the manufacturing, formulation, methods of use and/or processing of Aptamers (such Patent Rights hereinafter referred to as “Generic IP”). Archemix shall have the right to practice the Generic IP and to grant sublicenses to the Generic IP to Third Parties who have a license from Archemix to Archemix technology and/or intellectual property solely in order to permit Archemix or such Third Party to research, discover, make, have made, keep, use, sell and/or have sold, import or export Aptamers which are not subject to Nuvelo’s exclusive rights hereunder, and to the extent
Grantback. Upon Rigel’s written request provided to Lilly no later than within [*] days after the effective date of the termination at issue, Lilly shall, for a period not less than [*] days following the applicable effective date of such termination, negotiate with Rigel in good faith the terms of a non-exclusive, worldwide, fully-paid, perpetual, irrevocable, royalty-bearing license, with the right to grant multiple tiers of sublicenses, under such Lilly Technology as is necessary to Exploit the Terminated Compounds and Terminated Products, with any such agreed terms to be memorialized in a written agreement; provided that, where the Parties do not agree to terms within such [*] day period, [*].
Grantback. If during the course of conducting post marketing clinical trials (phase IV trials) in the LILLY Territory an invention is discovered that results in a patent, LILLY shall grant the Company a non-exclusive license to such patent with the right of the Company to grant sublicenses.
Grantback. Licensee hereby grants to AT&T and its Subsidiaries under any --------- Improvement Patents owned or controlled by Licensee or its Subsidiaries a non-exclusive, non-transferable, fully paid up, perpetual license to make have made, and use, but not sell, offer to sell, or import any products or services. For purposes of this Section 4.3, an "Improvement Patent" means a patent that includes a claim which is encompassed within the scope of one or more claims of the Licensed Patents. The license and rights hereby granted to AT&T and its Subsidiaries (a) shall survive termination of this Agreement, and (b) shall, in the case of an Improvement Patent owned or controlled by a Subsidiary of Licensee, continue after such Subsidiary is no longer a Subsidiary of Licensee.
Grantback. Notwithstanding anything in this Agreement to the contrary, and subject to Section 3.4, ARCA hereby grants to Archemix a non-exclusive, paid-up, royalty-free license to any ARCA Program Technology and ARCA Patent Rights covering such ARCA Program Technology that generically relates to and covers the manufacturing, formulation, methods of use and/or processing of Aptamers (such Patent Rights hereinafter referred to as “Generic IP”). Archemix shall have the right to practice the Generic IP and to grant sublicenses to the Generic IP to Third Parties who have a license from Archemix to Archemix technology and/or intellectual property solely in order to permit Archemix or such Third Party to research, discover, make, have made, keep, use, sell and/or have sold, import or export Aptamers which are not subject to ARCA’s exclusive rights hereunder. For clarity, the rights granted to Archemix by ARCA under this Section 3.6 are limited to the claims to Generic IP and no rights are granted under other claims in any patent or patent application of ARCA that contains the claim(s) which is (are) Generic IP.
Grantback. KISSEI shall keep VERTEX fully advised of any Compounds designed or discovered by KISSEI or any of its Affiliates, sublicensees and subcontractors as a result of work under the Research Program ("KISSEI Research Compound"), and any improvements made by KISSEI or its Affiliates or sublicensees relating to Compounds and Promising Processes during the term of the Research Program and the Development Program, whether patentable or not ("KISSEI Improvements"). KISSEI shall assign to VERTEX all of its rights to any such KISSEI Research Compounds and KISSEI Improvements, and any such KISSEI Research Compounds and KISSEI Improvements shall be considered Compounds and/or VERTEX Technical Information and subject to KISSEI's rights hereunder. KISSEI will seek to obtain similar rights in favor of VERTEX for any KISSEI Improvements generated or made available to it by its Affiliates and sublicensees, if any. VERTEX shall seek to obtain rights hereunder for KISSEI in the Territory for any such improvements generated or made available to VERTEX by its other licensees, if any.
Grantback. KISSEI shall keep VERTEX fully advised of any improvements made by KISSEI or any of its Affiliates, sublicensees and subcontractors relating to Promising Compounds and Promising Processes during the term of the Research Program and the Development Program, whether patentable or not ("KISSEI Improvements"). KISSEI shall assign to VERTEX all of its rights to any such KISSEI Improvements and any such KISSEI Improvements shall be considered Promising Compounds and/or VERTEX Technical Information and subject to KISSEI's rights hereunder with respect thereto, and KISSEI will seek to obtain similar rights in favor of VERTEX for any such Improvements generated or made available to it by its Affiliates, sublicensees and subcontractors, if any. VERTEX shall seek to obtain rights hereunder for KISSEI in the Territory for any such improvements generated or made available to VERTEX by its other licensees, if any.
Grantback. Nycomed and its Affiliates hereby grant to Medicis a perpetual (subject to section 5.3), royalty-free, fully-paid up, non-transferable (except as provided in Section 9.5), non-exclusive license (with the right to grant sublicenses through multiple tiers) under the Grantback Patents to make, have made, use, offer for sale, sell and import Vanos Products or Generic Equivalents in the Territory.
